Stocks & Investing
Thu, October 3, 2024
Thu, August 22, 2024
Tue, August 20, 2024
[ 12:00 AM ] - WOPRAI
Fri, August 2, 2024
[ 12:00 AM ] - WOPRAI
Tue, June 25, 2024
[ 12:00 AM ] - WOPRAI
Tue, June 18, 2024
[ 12:00 AM ] - WOPRAI
Wed, June 12, 2024
[ 12:00 AM ] - WOPRAI
Wed, May 15, 2024
Mon, April 1, 2024
Thu, March 7, 2024
[ 12:00 AM ] - WOPRAI
Fri, February 16, 2024
[ 12:00 AM ] - WOPRAI
Fri, December 8, 2023
[ 12:00 AM ] - WOPRAI
Fri, August 11, 2023
[ 12:00 AM ] - WOPRAI
Wed, June 14, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, May 16, 2023
[ 12:00 AM ] - WOPRAI
Wed, May 10, 2023
[ 12:00 AM ] - WOPRAI
Fri, May 5, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, April 28, 2023
[ 12:00 AM ] - WOPRAI
Thu, April 27, 2023
[ 12:00 AM ] - WOPRAI
Mon, April 3, 2023
Fri, March 24, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, March 17, 2023
Fri, March 10, 2023
[ 12:00 AM ] - WOPRAI
Tue, February 28, 2023 Tiago Fauth Initiated (VRNA) at Buy and Held Target at $50 on, Oct 3rd, 2024
Tiago Fauth of Wells Fargo, Initiated "Verona Pharma plc" (VRNA) at Buy and Held Target at $50 on, Oct 3rd, 2024.
Tiago has made no other calls on VRNA in the last 4 months.
There are 3 other peers that have a rating on VRNA. Out of the 3 peers that are also analyzing VRNA, 0 agree with Tiago's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Tiago
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $36 on, Tuesday, October 1st, 2024
- Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $37 on, Monday, July 22nd, 2024
- Joon Lee of "Truist Securities" Maintained at Strong Buy with Increased Target to $38 on, Friday, June 28th, 2024
